  | 
                       
                    
                        | 
                      accreditation 
                                          statements 
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University 
School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. 
 
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. 
 
The Institute for Johns
Hopkins Nursing and the American Nurses
Credentialing Center do not endorse the
use of any commercial products discussed
or displayed in conjunction with this
educational activity. 
 
                                           credit 
                                          designations 
                                          Physicians  
                                          Podcast: The Johns Hopkins University School 
of Medicine designates this enduring material 
for a maximum of 0.5 AMA PRA Category 1 Credit(s)�. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 
Nurses  
Podcast: This 0.5 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Podcast carries a maximum of 0.5 contact hours or a total of 3 contact hours for the six Podcasts in this program. 
 
To obtain contact hours, you must complete this Educational Activity and post�test by March 27, 2015. 
                                           
                                          Respiratory Therapists  
                                          For United States: Visit 
                                          this page to confirm that your state 
                                          will accept the CE Credits gained through 
                                          this program. 
                                           
                                          For Canada: Visit 
                                          this page to confirm that your province 
                                          will accept the CE Credits gained through 
                                          this program. 
                                           
                                          intended 
                                          audience  
This activity has been developed for pulmonologists, pediatric pulmonologists, gastroenterologists, pediatricians, infectious disease specialists, respiratory therapists, dieticians, nutritionists, nurses, and physical therapists. 
 
There are no fees or prerequisites for this activity. 
 
 launch date 
                                          This volume launched on  February 28, 2013, and is published monthly; activities expire two years from the date of publication. 
                                           
                                          STATEMENT OF NEED 
                                          Based on a review of the current literature, including national and   regional measures, detailed conversations with expert educators at Johns   Hopkins, and a survey of potential program participants, this program   will address the following core patient care gaps: 
                                           
Disease-Modifying Therapies 
                                          
                                          
                                            
                                                | 
                                              Clinicians may be unfamiliar with recently introduced disease-modifying   therapies and how they are altering the therapeutic landscape for   patients with cystic fibrosis. | 
                                             
                                            
                                                | 
                                             
                                            
                                                | 
                                              Clinicians may be uncertain how to integrate genotyping into therapeutic   decisions and how to communicate with patients and families about the   relationship between genotype and therapy | 
                                             
                                           
                                           
                                          Nutrition 
                                
                                          
                                            
                                            
                                                | 
                                              Many clinicians lack strategies to persuade patients to adhere to CF   nutritional requirements, resulting in low body weight and nutritional   failure in patients with cystic fibrosis. | 
                                             
                                            
                                                | 
                                             
                                            
                                                | 
                                              Many clinicians remain uncertain how to optimize pancreatic function in patients with cystic fibrosis. | 
                                             
                                           
                                           
                                          Treating CF Patients with Inhaled Antibiotics 
                                          
                                          
                                            
                                                | 
                                              Clinicians lack knowledge about the use of existing and emerging inhaled ABX to treat chronic pulmonary infections. | 
                                             
                                            
                                                | 
                                             
                                            
                                                | 
                                              Clinicians need more information to make informed decisions about the use of inhaled ABX in combination. | 
                                             
                                            
                                                | 
                                             
                                            
                                                | 
                                              Clinicians lack information about best practices for scheduling ABX therapy to suppress chronic airway infections. | 
                                             
                                            
                                                | 
                                             
                                            
                                                | 
                                              Common clinician assumptions about treating pulmonary exacerbations lack supporting evidence. | 
                                             
                                            
                                                | 
                                             
                                            
                                                | 
                                              CF clinicians are not aware of and/or are not actively advocating inhaled ABX patient-adherence strategies. | 
                                             
                                           
                                           
                                           hardware & software requirements 
Pentium 800 processor or greater, Windows 98/NT/2000/XP or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, Windows Media Player 9.0 or later, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader. 
 
                                            disclaimer 
                                          statement 
                                           The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is 
                                        produced for educational purposes only. Use of Johns Hopkins University School of Medicine  name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients. 
                                         
                                        faculty 
                                          disclosure 
                                           As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. 
Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity: 
                                          
                                          
                                            
                                                | 
                                              Michael P. Boyle, MD, FCCP discloses that he has received grant/research support from Vertex Pharmaceuticals, Inc, and is a consultant for Vertex, Novartis, Savara, Pharmaxis, Genentech, Inc., and Gilead Sciences, Inc. | 
                                             
                                            
                                                | 
                                             
                                            
                                                | 
                                              No other planners have indicated that they have any financial interests or relationships with a commercial entity. | 
                                             
                                            
                                            
                                                | 
                                             
                                            
                                              | Guest Author's Disclosures | 
                                             
                                           
                                 | 
                        | 
                       
                    
                        | 
                       
                     
                     
                       | 
                    | 
                  
                    
                        | 
                       
                    
                       
  | 
                      SUCCESSFUL COMPLETION 
To take the post-test for eCysticFibrosis Review you will need to visit the Johns Hopkins University School of Medicine's CME website and the Institute for Johns Hopkins Nursing. If you have already registered for other Hopkins CE programs at these sites, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. A passing grade of 70% or higher on the post-test/evaluation is required to receive CE credit. 
 
Estimated time to complete activity: 30 minutes.
  
                      statement 
                                          of responsibility   
The Johns Hopkins University School 
                                          of Medicine takes responsibility 
                                          for the content, quality and scientific 
                                          integrity of this CME activity.  
                                           
                                          CONFIDENTIALITY DISCLAIMER FOR CME CONFERENCE ATTENDEES   
I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.  
 
I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations").  Protected health information is information about a person's health or treatment that identifies the person.  
 
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. 
 
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality.  The contact information is:  Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.  
 
"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."  
 
For CME Questions, please contact the CME Office at (410) 955-2959 or e-mail cmenet@jhmi.edu. 
For CME Certificates, please call (410) 502-9634.  
 
Johns Hopkins University School of Medicine 
Office of Continuing Medical Education 
Turner 20/720 Rutland Avenue 
Baltimore, Maryland 21205-2195 
 
Reviewed & Approved by: 
General Counsel, Johns Hopkins Medicine (4/1/03) 
Updated 4/09  
 
internet 
                                          cme/ce policy  
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine  is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.  
 
Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside the Johns Hopkins University School of Medicine's CME program.  CME collects only the information necessary  
to provide you with the services that you request.  | 
                        | 
                       
                    
                        | 
                       
                      |